Disclosures for "Multi-thalamic Neuromodulation Improves Seizure Outcome in SCN1A-Dravet Syndrome: Insights from Ambulatory Electrothalamogram"
-
Dr. Nayak has nothing to disclose.
-
Mr. Vashin has nothing to disclose.
-
Mr. Vakilna has nothing to disclose.
-
The institution of Dr. Lhatoo has received research support from NIH. Dr. Lhatoo has received intellectual property interests from a discovery or technology relating to health care. Dr. Lhatoo has received publishing royalties from a publication relating to health care.
-
Dr. Pati has nothing to disclose.